AI-generated summary
The authors compared a 308-nm excimer laser with 311-nm narrow-band UVB phototherapy in a split-body trial of 16 patients with psoriasis, with 15 evaluated after 12 treatments. In 9 patients the laser-treated lesions improved more, and in 4 the UVB-treated side cleared more. The mean PASI reductions (5.6 and 4.9) were not significantly different, and the authors concluded the laser is an additional effective option.
- Participants
- 16
- Who or what was studied
- Patients with psoriasis vulgaris (16 enrolled, 15 evaluated)
- Wavelengths
- 308, 311 nm
- Limits stated in the abstract
- The trial was small, open and single-blinded, and the mean PASI difference between treatments was not statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on karger.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 311 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.